Effectiveness of STOPP/START criteria in primary prevention of polypharmacy and under-treatment in older patients

Basit Öğe Kaydı
dc.authoridengin, velittin selcuk/0000-0002-6338-4748
dc.authoridBenli, Ali Ramazan/0000-0003-0039-1497
dc.authoridErsoy, Suleyman/0000-0003-0001-9329
dc.contributor.authorPala, Emin
dc.contributor.authorErsoy, Suleyman
dc.contributor.authorEngin, Velittin Selcuk
dc.contributor.authorBenli, Ali Ramazan
dc.date.accessioned2024-09-29T16:00:48Z
dc.date.available2024-09-29T16:00:48Z
dc.date.issued2022
dc.departmentKarabük Üniversitesien_US
dc.description.abstractAim of the study. - STOPP/START criteria appear to be a useful tool to curb inappropriate prescribing (IP), which encompasses errors of both, over and under-treatment. This study aimed to find out whether application of STOPP/START reduces the IP effectively in primary care. Methods. - This prospective cross-sectional study was conducted in two family health centers (FHCs) in Istanbul. All older adults who applied to FHCs between 01-07-2018 and 01-072020 were enrolled. The potential inappropriate medications (PIMs) and potential prescription omissions (PPOs) were identified according to STOPP/START version 2 criteria. Mean drug consumptions before and after STOPP/START were compared using Student's t-test. Results. - Among 1023 participants there were 626 females and 397 males. The mean age was 73.33 +/- 7.30 years. The number of the patients seen at FHCs was 657 (64.2%) while 366 (35.8%) of them were visited at home. Of the patients, 383 (37.8) were 75 years old or older and 631 (62.2%) of them were under 75. Overall number of drugs consumed per patient was 5.49 +/- 3.93 while it was 6.01 +/- 3.71 and 4.55 +/- 4.138 for outpatients and home patients respectively (p < 0.001). By application of STOPP criteria, among the 5616 medications consumed by the overall patients, 881(%15.6) of them were found to be potentially inappropriate. 424 (41.4%) patients were using at least one PIM. This ratio was 354 (53.8%) in outpatients and 70 (19%) in home patients. START criteria identified 380 (%7.4) PPOs. There were 246 (24.0%) patients at least with one PPO; 155 (42.3%) of whom were home patients and 91 (13.8%) were outpatients. Regarding the age groups; PIM ratio was 35.5% in patients under 75 and 52.1% over 75 whereas PPO ratio was 22.5% under 75 and 26.8% over 75. Conclusion. - This study supports the data reporting the effectiveness of STOPP/START criteriain primary care units in implementing appropriate prescription criteria. (C) 2021 Societe francaise de pharmacologie et de therapeutique. Published by Elsevier MassonSAS. All rights reserved.en_US
dc.identifier.doi10.1016/j.therap.2021.07.003
dc.identifier.endpage369en_US
dc.identifier.issn0040-5957
dc.identifier.issn1958-5578
dc.identifier.issue3en_US
dc.identifier.pmid34454744en_US
dc.identifier.scopus2-s2.0-85120646832en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage361en_US
dc.identifier.urihttps://doi.org/10.1016/j.therap.2021.07.003
dc.identifier.urihttps://hdl.handle.net/20.500.14619/5373
dc.identifier.volume77en_US
dc.identifier.wosWOS:000833546700013en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofTherapieen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSTOPPen_US
dc.subjectSTART criteriaen_US
dc.subjectRational drug useen_US
dc.subjectPrimary careen_US
dc.subjectPolypharmacyen_US
dc.subjectUnder-treatmenten_US
dc.titleEffectiveness of STOPP/START criteria in primary prevention of polypharmacy and under-treatment in older patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu